These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8229078)

  • 1. The lack of accumulation of senile plaques or amyloid burden in Alzheimer's disease suggests a dynamic balance between amyloid deposition and resolution.
    Hyman BT; Marzloff K; Arriagada PV
    J Neuropathol Exp Neurol; 1993 Nov; 52(6):594-600. PubMed ID: 8229078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.
    Lemere CA; Blusztajn JK; Yamaguchi H; Wisniewski T; Saido TC; Selkoe DJ
    Neurobiol Dis; 1996 Feb; 3(1):16-32. PubMed ID: 9173910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mostly separate distributions of CLAC- versus Abeta40- or thioflavin S-reactivities in senile plaques reveal two distinct subpopulations of beta-amyloid deposits.
    Kowa H; Sakakura T; Matsuura Y; Wakabayashi T; Mann DM; Duff K; Tsuji S; Hashimoto T; Iwatsubo T
    Am J Pathol; 2004 Jul; 165(1):273-81. PubMed ID: 15215182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease amyloid-beta links lens and brain pathology in Down syndrome.
    Moncaster JA; Pineda R; Moir RD; Lu S; Burton MA; Ghosh JG; Ericsson M; Soscia SJ; Mocofanescu A; Folkerth RD; Robb RM; Kuszak JR; Clark JI; Tanzi RE; Hunter DG; Goldstein LE
    PLoS One; 2010 May; 5(5):e10659. PubMed ID: 20502642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in beta-amyloid (beta/A4) deposition in human patients with Down's syndrome and sporadic Alzheimer's disease.
    Armstrong RA
    Neurosci Lett; 1994 Mar; 169(1-2):133-6. PubMed ID: 8047269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of beta-amyloid deposition in the medial temporal lobe in sporadic Alzheimer's disease, Down's syndrome and normal elderly brains.
    Armstrong RA; Cairns NJ; Myers D; Smith CU; Lantos PL; Rossor MN
    Neurodegeneration; 1996 Mar; 5(1):35-41. PubMed ID: 8731380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of the morphology and distribution of amyloid beta protein immunoreactive plaque and related lesions in the brains of Alzheimer's disease and adult Down's syndrome.
    Ikeda S; Allsop D; Glenner GG
    Prog Clin Biol Res; 1989; 317():313-23. PubMed ID: 2532370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-Amyloid peptide and amyloid precursor proteins in olfactory mucosa of patients with Alzheimer's disease, Parkinson's disease, and Down syndrome.
    Crino PB; Martin JA; Hill WD; Greenberg B; Lee VM; Trojanowski JQ
    Ann Otol Rhinol Laryngol; 1995 Aug; 104(8):655-61. PubMed ID: 7639477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome.
    Snow AD; Mar H; Nochlin D; Sekiguchi RT; Kimata K; Koike Y; Wight TN
    Am J Pathol; 1990 Nov; 137(5):1253-70. PubMed ID: 2146882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical and immunological heterogeneity of fibrillar amyloid in plaques of Alzheimer's disease and Down's syndrome brains revealed by confocal microscopy.
    Schmidt ML; Robinson KA; Lee VM; Trojanowski JQ
    Am J Pathol; 1995 Aug; 147(2):503-15. PubMed ID: 7639340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain amyloid-beta fragment signatures in pathological ageing and Alzheimer's disease by hybrid immunoprecipitation mass spectrometry.
    Portelius E; Lashley T; Westerlund A; Persson R; Fox NC; Blennow K; Revesz T; Zetterberg H
    Neurodegener Dis; 2015; 15(1):50-7. PubMed ID: 25591542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deposition of apolipoproteins E and J in senile plaques is topographically determined in both Alzheimer's disease and Down's syndrome brain.
    Kida E; Choi-Miura NH; Wisniewski KE
    Brain Res; 1995 Jul; 685(1-2):211-6. PubMed ID: 7583250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofibrillary Tangles of Aβx-40 in Alzheimer's Disease Brains.
    Lacosta AM; Insua D; Badi H; Pesini P; Sarasa M
    J Alzheimers Dis; 2017; 58(3):661-667. PubMed ID: 28453491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Size frequency distributions of β-amyloid (Aβ) deposits: a comparative study of four neurodegenerative disorders.
    Armstrong RA
    Folia Neuropathol; 2012; 50(3):240-9. PubMed ID: 23023338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Elucidating Pathogenic Mechanisms of Early-onset Alzheimer's Disease in Down Syndrome Patients].
    Asai M; Kawakubo T; Mori R; Iwata N
    Yakugaku Zasshi; 2017; 137(7):801-805. PubMed ID: 28674290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
    Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The presence of isoaspartic acid in beta-amyloid plaques indicates plaque age.
    Fonseca MI; Head E; Velazquez P; Cotman CW; Tenner AJ
    Exp Neurol; 1999 Jun; 157(2):277-88. PubMed ID: 10364440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HNE-modified proteins in Down syndrome: Involvement in development of Alzheimer disease neuropathology.
    Barone E; Head E; Butterfield DA; Perluigi M
    Free Radic Biol Med; 2017 Oct; 111():262-269. PubMed ID: 27838436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of senile plaques in Alzheimer disease: observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome).
    Hyman BT; West HL; Rebeck GW; Buldyrev SV; Mantegna RN; Ukleja M; Havlin S; Stanley HE
    Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3586-90. PubMed ID: 7724603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.